People – Page 3
-
NewsMass polio vaccination campaign to continue in the Gaza Strip
The emergency polio outbreak response in the Gaza Strip is continuing, with a mass vaccination campaign scheduled from 22 to 26 February 2025. The novel oral polio vaccine type 2 (nOPV2) will be administered to over 591,000 children under 10 years of age.
-
NewsProfessor awarded NSF grant to advance research on silica-scaled chrysophytes
A new National Science Foundation (NSF) grant will support a major effort to synthesize decades of research on protists. The project will integrate findings from Professor Peter Siver’s lifelong study of silica-scaled chrysophytes, a group of protists found in freshwater environments.
-
NewsScientists to forecast climate tipping points by capturing ocean’s pulse - plankton
A new project is set to revolutionise climate forecasting by focusing on plankton as the “canaries in the coalmine” of ocean health. Next-generation autonomous underwater robots will deliver near real-time observations in the North Atlantic subpolar gyre.
-
NewsProfessor Cristobal Uauy appointed as Director of the John Innes Centre
Following an international search, Professor Cristóbal Uauy has been appointed as the next Director of the John Innes Centre.
-
NewsResearchers explore Spanish flu’s impact on Appalachia
A new book examines how the 1918 influenza pandemic disproportionately impacted Appalachian communities, exacerbating long-standing health disparities. Those included limited health care access, poor working conditions and systemic poverty.
-
NewsInternational team publishes guideline on how to manage fungal infections caused by Candida
The new global guideline for the diagnosis and treatment of Candida infections establishes new standards for managing fungal infections, which affect millions of people worldwide every year.
-
NewsHarvard Pilgrim Health Care Institute announces launch of Center for Sepsis Epidemiology and Prevention Studies (SEPSIS)
The new Center for Sepsis Epidemiology and Prevention Studies (SEPSIS) is a pioneering center of excellence dedicated to advancing understanding, prevention, and management of sepsis, a life-threatening condition caused by a dysregulated immune response to infection.
-
-
NewsNasal COVID-19 vaccine to enter US clinical trials
A nasal vaccine for COVID-19 is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug application from Ocugen, Inc. was approved by the Food and Drug Administration (FDA).
-
NewsNIH awards $20.6 million grant to establish Human Virome Characterization Center at UCLA
NIH has awarded a $20.6 million grant over five years to establish one of five Human Virome Characterization Centers to advance understanding of the virome’s role in human health and disease across the oral-gut-brain axis.
-
NewsHow worried should we be about bird flu? An expert explains.
As U.S. health officials announce that a new strain of avian flu, H5N9, has been discovered on a duck farm in California, UC Berkeley School of Public Health’s John Swartzberg opens up on how much of a threat it poses.
-
NewsGroundbreaking Ebola vaccination trial launches in Uganda
In a global first, Uganda’s Ministry of Health, the World Health Organization (WHO) and other partners have launched a first ever vaccine trial for Ebola from the Sudan species of the virus, and at an unprecedented speed for a randomized vaccine trial in an emergency. Source: CDC Global ...
-
NewsUrgent action needed to keep Europe polio-free, warn heads of ECDC and WHO Europe
An unusually high amount of poliovirus detections in several European countries in recent months has underscored the importance of keeping Europe polio-free.
-
NewsScientists probe honeybee antiviral defense mechanisms
Scientists are investigating honeybee antiviral defense mechanisms with the goal of developing strategies to reduce honeybee colony deaths.
-
NewsNIH-funded clinical trial will evaluate new dengue therapeutic
A clinical trial is testing an experimental treatment designed to help people suffering the effects of dengue. An investigational therapeutic will be administered to adult volunteers who have been exposed to a weakened strain that causes a mild form of the disease.
-
NewsWHO and partners enable access to candidate vaccine and treatments for outbreak of Sudan Ebola virus disease in Uganda
WHO and partners have immediately boosted their support to the Ugandan government’s response to an outbreak of Sudan virus disease outbreak (SVD, part of the Ebola family), including by facilitating access to a candidate vaccine and candidate treatments.
-
NewsWHO verifies Niger as the first country in the African Region to eliminate onchocerciasis
Niger has met the criteria for onchocerciasis elimination, making it the fifth country globally and the first country in Africa to be acknowledged by WHO for interrupting transmission of the parasite Onchocerca volvulus.
-
NewsGuinea eliminates human African trypanosomiasis as a public health problem
The World Health Organization (WHO) has congratulated Guinea for eliminating the gambiense form of human African trypanosomiasis as a public health problem. This is the first neglected tropical disease to be eliminated in the country.
-
NewsCARB-X funds Rhode Island Hospital to assess feasibility of direct from blood detection of bacterial pneumonia
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award Rhode Island Hospital at Brown University Health US$1M to demonstrate proof-of-concept of a polymerase chain reaction (PCR) approach informed by RNA sequencing to detect bacterial pneumonia directly from whole blood.
-
NewsGeorgia certified malaria-free by WHO
After 9 years of declaration for zero indigenous cases of malaria and being recognised by the WHO, Georgia has finally been certified malaria-free and is willing to commit to remain the current status.